Burlington, VT, United States of America

Joseph Klaus

This inventor holds 1 USPTO granted patent. Top assignee: University of Vermont. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph Klaus: Innovator in Viral Infection Reduction

Introduction

Joseph Klaus is a notable inventor based in Burlington, Vermont. He has made significant contributions to the field of virology through his innovative research and patent work. His focus on reducing the infectivity of virus particles has the potential to impact public health positively.

Latest Patents

Joseph Klaus holds a patent titled "Methods and compositions for reducing infectivity of virus particles comprising an ERGIC-53 polypeptide." This invention relates to compounds, compositions, and methods aimed at reducing the infectivity of virus particles and treating viral infections in subjects. His work in this area is crucial for developing effective treatments for viral diseases.

Career Highlights

Klaus is affiliated with the University of Vermont, where he conducts his research and collaborates with other experts in the field. His dedication to advancing scientific knowledge and practical applications in virology is evident in his work.

Collaborations

Joseph Klaus has worked alongside notable colleagues such as Jason William Botten and Anne B Mason. Their combined expertise enhances the research efforts at the University of Vermont, fostering an environment of innovation and discovery.

Conclusion

Joseph Klaus is a prominent figure in the field of virology, with a focus on reducing viral infectivity through innovative methods and compositions. His contributions are vital for the ongoing fight against viral infections, and his work continues to inspire future research in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…